True hermaphroditism with seminoma: A case report

Lai,Yulin; Xie,Jiansen; Tian,Peikai; Zhong,Liming; Ni,Liangchao

doi:10.3892/mco.2018.1760

True hermaphroditism with seminoma: A case report

Authors:
- Yulin Lai
- Jiansen Xie
- Peikai Tian
- Liming Zhong
- Liangchao Ni
View Affiliations

Affiliations: Department of Urology, Peking University Shenzhen Hospital, Institute of Urology, Shenzhen PKU‑HKUST Medical Center, Shenzhen, Guangdong 518036, P.R. China, Department of Hepatobiliary Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China, Department of Hepatobiliary Surgery, Shenzhen University General Hospital, Shenzhen, Guangdong 518036, P.R. China
Published online on: November 8, 2018 https://doi.org/10.3892/mco.2018.1760
Pages: 97-100

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to discuss the diagnosis and treatment of a patient with true hermaphroditism complicated by seminoma. The patient was a 35‑year‑old man who was admitted to the Peking University Shenzhen Hospital with a retractable mass in the left inguinal region for 20 years. A computed tomography examination revealed right cryptorchidism. The postoperative pathology suggested true hermaphroditism with a seminoma. The results of immunohistochemical examination were as follows: Sal‑like protein 4+ (partially weak); octamer‑binding transcription factor 4+ (partially weak); CD117+; cytokeratin+; CD30‑, α‑fetoprotein‑, inhibin‑α‑. The karyotype was 46, XY. Adult true hermaphroditism combined with seminoma is rare in clinical practice. Combined histopathological analysis, immunophenotype detection and karyotype analysis are of great value in the diagnosis and differential diagnosis. Early intervention and combined surgery with radiotherapy and chemotherapy can significantly improve the prognosis of such patients.

View Figures

View References

1	Liang YF: The hermaphroditism of human. Biologic Teach. 29:51–52. 2004.
2	Jing H, Xinhua T and Baosheng Z: 46,XX male syndrome genetic diagnosis and clinical analysis. Chin J Androl. 17:68–72. 2011.(In Chinese).
3	Mendonca BB, Domenice S, Arnhold IJ and Costa EM: 46, XY disorders of sex development (DSD). Clin Endocrinol (Oxf). 70:173–187. 2009. View Article : Google Scholar : PubMed/NCBI
4	Yanqin Y and Xiaoping L: Diagnosis and differentiation program of sexual development disorder. J Clin Pediatr. 25:965–970. 2007.
5	Xiaoyu C and Shulan Z: Research progress of the correlation between Y-box protein 2 and gynecologic malignancy in sex determination area. Chin J Pract Gynecol Obst. 31:1048–1051. 2015.
6	Xia XY, Cui YX, Lu HY, Yang B, Wang GH, Pan LJ, Hou BS, Ge YF, Shao Y, Yao B and Huang YF: Clinical, molecular and cytogenetic studies on 4 patients with 46,XX (SRY positive) male syndrome. Zhonghua Nan Ke Xue. 13:1094–1097. 2007.(In Chinese). PubMed/NCBI
7	Martin OV, Shialis T, Lester JN, Scrimshaw MD, Boobis AR and Voulvoulis N: Testicular dysgenesis syndrome and the estrogen hypothesis: A quantitative meta-analysis. Environ Health Perspect. 116:149–157. 2008. View Article : Google Scholar : PubMed/NCBI
8	Enhao G: Modern plastic surgery. Beijing: People's Military Medical Press; pp. 921–933. 2002
9	Deng M, Zhao H, Che Z, Wang R, Qi H and Nie W: Report of 1 case of true hermaphroditism and literature review. Chin J Androl. 26:55–56. 2012.(In Chinese).
10	Zeyi C: Chinese obstetrics and gynecology. Beijing: People's Medical Publishing House; 2014
11	Cui J, Dou JT, Yang GG, Gu WJ, Zang L, Jin N, Wang XL, Yang LJ, Lu ZH, Ba JM, et al: Diagnosis and management of ovotesticular disorders of sex development: A clinical study of 14 cases. Chin J Pract Int Med. 4:346–350. 2015.
12	Boujelbene N, Cosinschi A, Boujelbene N, Khanfir K, Bhagwati S, Herrmann E, Mirimanoff RO, Ozsahin M and Zouhair A: Pure semiuoma: A review and update. Radiat Oneol. 6:902011. View Article : Google Scholar
13	Tickoo SK, Hutchinson B, Bacik J, Mazumdar M, Motzer RJ, Bajorin DF, Bosl GJ and Reuter VE: Testicular seminoma: A clinicopathologic and immunohistechemical study of 105 cases with special reference to seminomas with atypical features. Int J Surg Pathol. 10:23–32. 2002. View Article : Google Scholar : PubMed/NCBI
14	Tazi H, Badraoui M, Qasmi S and Hassam B: Metastatie pure testicular seminoma of the skin. Prog Urol. 21:76–78. 2011.(In French). View Article : Google Scholar : PubMed/NCBI
15	Yinghao Y: Immunohistochemical diagnosis and differential diagnosis of testicular tumors. Chin J Misdiagnosis. 543–546. 2006.
16	Liu DL, Lu YP, Shi HY, Zhu SX, Lü JW, Li WF and Rong X: Expression of CD117 in human testicular germ cell tumors and its diagnostic value for seminoma and nonseminoma. Zhonghua Nan Ke Xue. 14:38–41. 2008.(In Chinese). PubMed/NCBI
17	Biermann K, Klingmüller D, Koch A, Pietsch T, Schorle H, Büttner R and Zhou H: Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-KIT in the detection of extragonadal seminomas. Histopathology. 49:290–297. 2006. View Article : Google Scholar : PubMed/NCBI
18	Ying T, Yuanhua C and Anzhi W: Expression and significance of M2A,AP-2γ,OCT3/4, PLAP and CD117 in seminoma. J Pract Med. 27:1338–1340. 2011.
19	Bode PK, Barghorn A, Fritzsche FR, Riener MO, Kristiansen G, Knuth A and Moch H: MAGEC2 is a sensitive and novel marker for seminoma: A tissue microarray an analysis of 325 testicular germ cell tumors. Mod Pathol. 24:829–835. 2011. View Article : Google Scholar : PubMed/NCBI
20	Davis-Dao CA, Siegmund KD, Vandenberg DJ, Skinner EC, Coetzee GA, Thomas DC, Pike MC and Cortessis VK: Heteregenous effect of androgen receptor CAG tract length on testicular germ cell tumor risk: Shorter repeats associated with seminoma but not other histology types. Carcinogenesis. 32:1238–1243. 2011. View Article : Google Scholar : PubMed/NCBI
21	Zhenhua L, Tao X and Yunbei X: Tissue microarray technique was used to detect the expression of CMTM2 in human testicular tumor tissues. Chin J Male Sci. 23:3–6. 2011.(In Chinese).
22	Gang L, Bo Y and Yongsheng S: Clinical analysis of 15 cases of secondary malignant transformation of cryptorchidism. J Beihua Univ (Nat Sci). 13:557–559. 2012.(In Chinese).
23	Bigot P, Droupy S, Houlgatte A, De Crevoisier R and Fléchon A: Stage I seminoms: Therapeutic strategy: Surveillance, radiotherapy, chemotherapy. A case-report. Prog Urol. 21 Suppl 2:S453–S457. 2011.
24	Yang Z and Daguang W: Pelvic tumor characteristics and diagnosis and treatment. Chin J Pract Surg. 31:533–535. 2011.(In Chinese).
25	Zhiyu W, Jian C, Lichang L, et al: Bilateral cryptorchidism complicated with unilateral malignant seminoma: A case report. Chin J Androl. 16:662–663. 2010.(In Chinese).
26	Yu L and Xin X: Report of a case of true glandular malignant glandular malignant transformation. Chin J Aesthetic Med. 3:326–327. 2004.(In Chinese).
27	Hua X, Liu SJ, Lu L, Li CX and Yu LN: Clinicopathological characterization of true hermaphroditism complicated with seminoma and review of the literature. Chin J Androl. 18:719–722. 2012.(In Chinese).
28	Eble JN, Sauter G, Epstein JI and Sesterhenn IA: World Health Organization Classification of TumoursPathology and genetics of tumours of Urinary system and male genital organs. Lyon: IARCP Press; pp. 260–261. 2004
29	Qiao B and Wen Z: The diagnostic criteria and treatment plan of cryptorchidism in children. Pract J Pediatr. 27:1847–1848. 2012.